Hikal Ltd.
Hikal
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹48.42 Cr.
EX-Date | Purpose |
---|---|
06 05 2021 | Audited Results & Final Dividend |
05 08 2021 | Quarterly Results |
26 10 2021 | Quarterly Results |
14 02 2022 | Quarterly Results & Interim Dividend Inter alia, to consider and approve : b. payment of interim dividend on the equity shares of the Company for the financial year 2021-22, if any; and c. issuance of non-convertible debentures on private placement basis. |
28 05 2022 | Final Dividend & Audited Results |
10 08 2022 | Quarterly Results |
09 11 2022 | Quarterly Results |
02 02 2023 | Interim Dividend & Quarterly Results |
29 05 2023 | Quarterly Results & Final Dividend & Audited Results |
08 08 2023 | Quarterly Results |
02 11 2023 | Quarterly Results |
08 02 2024 | Quarterly Results & Interim Dividend |
12 11 2024 | Quarterly Results |
04 02 2025 | Quarterly Results & Interim Dividend |
14 05 2025 | Final Dividend & Audited Results |
No News data available